Issue in Honor of Prof. Anthony J. Arduengo, III
ARKIVOC 2012 (ii) 74-84
(m, 1H), 2.10 (s, 3H), 2.06–1.98 (m, 1H), 1.66–1.58 (m, 1H), 0.95 (d, J = 6.5 Hz, 3H). 13C NMR
(100 MHz, CDCl3) δ 212.7, 138.5, 128.6, 127.9, 119.2, 73.2, 68.1, 44.2, 32.9, 28.6, 16.6; MS
(GC/MS) m/z 206 (M+), 178, 119, 99, 91 (100%).
tert-Butyl N-3-methyl-4-oxopentyl-N-tosylcarbamate (4c). IR (neat, cm-1) 3070, 2985, 1709,
1
1729, 1356, 1157. H NMR (400MHz, CDCl3) δ 7.50 (d, J = 8.1Hz, 2H), 7.29 (d, J = 8.1 Hz,
2H), 3.79 (t, J = 6.5 Hz, 2H), 2.69–2.62 (m, 1H), 2.42 (s, 3H), 2.20 (s, 3H), 2.19–1.99 (m, 1H),
13
1.81–1.72 (m, 1H), 1.33 (s, 9H), 1.1 (d, J = 7.3 Hz, 3H). C NMR (100 MHz, CDCl3) δ 211.8,
151.2, 144.4, 137.5, 129.5, 128.0, 84.6, 45.6, 44.6, 32.8, 28.2, 28.1, 21.8, 16.8; MS (GC/MS) m/z
369 (M+), 251, 186, 155, 96 (100%); ESI-HRMS m/z calcd. for C18H27NO5SNa [M+Na]+
392.1508, found 392.1506.
1
5,5-Diethoxy-3-methylpentan-2-one (6). IR (neat, cm-1) 2978, 1711, 1461, 1114. H NMR
(400MHz, CDCl3) δ 4.51 (t, J = 6.5 Hz, 1H), 3.63–3.60 (m, 2H), 3.50–3.45 (m, 2H), 2.67 (m,
1H), 2.10 (s, 3H), 2.07–1.96 (m, 1H), 1.83–1.75 (m, 1H), 1.20 (t, J = 6.9 Hz, 6H), 1.09 (d, J =
7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 211.7, 102.5, 61.3, 35.7, 28.4, 26.1, 16.3, 15.5.
1
3-Methyl-4-phenylbutan-2-one (8). IR (neat, cm-1) 3040, 2971, 2931, 1710, 1454, 1359. H
NMR (400MHz, CDCl3) δ 7.78–7.15 (m, 5H), 2.99 (dd, J = 6.4, 13.0 Hz, 1H), 2.83 (m, 1H),
2.56 (dd, J = 7.3, 13.0 Hz, 1H), 2.08 (s, 3H), 1.09 (d, J = 7.3 Hz, 3H). 13C NMR (100 MHz,
CDCl3) δ 212.5, 139.9, 129.2, 129.1, 128.7, 126.5, 49.1, 39.1, 29.1, 16.5; MS (GC/MS) m/z 162
(M+), 147, 119, 91 (100%).
1
(E)-Oct-5-en-3-one (10). IR (neat, cm-1) 2971, 2931, 1710, 1455, 1267. H NMR (400MHz,
CDCl3) δ 5.60–5.48 (m, 2H), 3.10 (d, J = 6.5 Hz, 2H), 2.45 (q, J = 7.3 Hz, 2H), 2.13–2.08 (m,
13
2H), 1.41 (t, J = 7.3 Hz, 3H), 0.96 (t, J = 7.3 Hz, 3H). C NMR (100 MHz, CDCl3) δ 211.1,
136.8, 121.2, 46.6, 35.5, 25.4, 13.8, 7.9; MS (GC/MS) m/z 126 (M+), 111, 69 (100%).
6-Ethyloctan-3-one (12). IR (neat, cm-1) 2985, 1717, 1459, 1102. 1H NMR (400MHz, CDCl3) δ
13
2.40–2.25 (m, 4H), 1.45–1.22 (m, 7H), 1.01 (t, J = 7.3 Hz, 6H), 0.95 (t, J = 7.3 Hz, 3H). C
NMR (100 MHz, CDCl3) δ 211.0, 43.6, 40.1, 35.8, 28.7, 25.4, 13.8, 7.9; MS (GC/MS) m/z 156
(M+), 125, 109, 85 (100%).
13,13-Diisopropyl-2,2,9,14-tetramethyl-3,3-diphenyl-4,12-dioxa-3,13-disilapentadecan-8-
1
one (14a). IR (neat, cm-1) 2937, 2870, 1711, 1267, 1101. H NMR (400MHz, CDCl3) δ 7.71–
7.61 (m, 4H), 7.40–7.31 (m, 6H), 3.69–3.60 (m, 4H), 2.79–2.71 (m, 1H), 2.60–2.50 (m, 2H),
1.98–1.90 (m, 1H), 1.81–1.75 (pentet, J = 6.4 Hz, 2H), 1.50–1.42 (m, 1H), 1.10 (d, J = 7.3 Hz,
3H), 1.10–1.00 (m, 30H). 13C NMR (100 MHz, CDCl3) δ 214.4, 135.7, 134.0, 129.8, 127.9, 63.2,
61.2, 42.9, 37.5, 36.1, 30.5, 27.1, 26.8, 19.4, 18.2, 16.6, 12.2; ESI-HRMS m/z calcd. for
C31H50O3Si2Na [M+Na]+ 577.3507, found 577.3493.
5-Methyl-4-oxo-7-((triisopropylsilyl)oxy)heptyl pivalate (14b). IR (neat, cm-1) 2938, 2866,
1713, 1750, 1459, 1157, 1099. 1H NMR (400MHz, CDCl3) δ 4.20 (t, J = 6.5 Hz, 2H), 3.68 (t, J =
7.3 Hz, 2H), 2.81–2.78 (m, 1H), 2.59–2.52 (m, 1H), 1.94–1.60 (m, 3H), 1.54–1.46 (m, 1H), 1.19
(s, 9H), 1.10–1.02 (m, 25 H). 13C NMR (100 MHz, CDCl3) δ 213.7, 178.7, 63.8, 61.1, 42.8, 38.9,
37.5, 36.7, 36.1, 36.0, 32.8, 27.4, 26.6, 23.3, 23.0, 18.2, 17.3, 16.6, 12.1; MS (GC/MS) m/z 357,
Page 82
©ARKAT-USA, Inc.